Temperature Rise Caused by Short or Long-wavelengths
Launched by UNIVERSITY OF FLORIDA · May 13, 2024
Trial Information
Current as of February 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Light-cured materials revolutionized dentistry as they allowed to control the setting of the materials in a timely manner simply upon light exposure. Although blue light has been routinely used to cure dental restorative materials for over 50 years, there are still potential risks to dental patients. These risks include gingiva burn or recession and pulp inflammation that can lead to necrosis in more severe situations due to the heat generated by this short wavelength (blue light). In addition, blue light has direct deleterious effects on cells, including irreversible imbalance in reactive ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I classification
- • Fully erupted pre-molar(s);
- • Absence of caries;
- • Absence of restoration.
- Exclusion Criteria:
- • Radiographic constriction of the pulp chamber;
- • Absence of apical closure;
- • Formation of pulp stones or diffuse calcification at the pulp chamber;
- • Presence of active carious lesions;
- • Diagnosed reversible or irreversible pulpitis;
- • Existing periapical lesion;
- • Existing or planned root canal treatment.
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0